The value of models in informing resource allocation in colorectal cancer screening: The case of the Netherlands
In May 2011, the Dutch government decided to implement a national programme for colorectal cancer (CRC) screening using biennial faecal immunochemical test screening between ages 55 and 75. Decision modelling played an important role in informing this decision, as well as in the planning and impleme...
| Main Authors: | Van Hees, F., Zauber, A., Van Veldhuizen, H., Heijnen, M., Penning, C., De Koning, H., Van Ballegooijen, M., Lansdorp_Vogelaar, Iris |
|---|---|
| Format: | Journal Article |
| Published: |
2015
|
| Online Access: | http://hdl.handle.net/20.500.11937/50129 |
Similar Items
Should colorectal cancer screening be considered in elderly persons without previous screening?: A cost-effectiveness analysis
by: Van Hees, F., et al.
Published: (2014)
by: Van Hees, F., et al.
Published: (2014)
Personalizing Colonoscopy Screening for Elderly Individuals Based on Screening History, Cancer Risk, and Comorbidity Status Could Increase Cost Effectiveness
by: Van Hees, F., et al.
Published: (2015)
by: Van Hees, F., et al.
Published: (2015)
Contribution of screening and survival differences to racial disparities in colorectal cancer rates
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)
The appropriateness of more intensive colonoscopy screening than recommended in medicare beneficiaries: A modeling study
by: Van Hees, F., et al.
Published: (2014)
by: Van Hees, F., et al.
Published: (2014)
Developing a score chart to improve risk stratification of patients with colorectal adenoma
by: Van Heijningen, E., et al.
Published: (2016)
by: Van Heijningen, E., et al.
Published: (2016)
Optimal colorectal cancer screening in states' low-income, uninsured populations - The case of South Carolina
by: Van Der Steen, A., et al.
Published: (2015)
by: Van Der Steen, A., et al.
Published: (2015)
The impact of stratifying by family history in colorectal cancer screening programs
by: Goede, S., et al.
Published: (2015)
by: Goede, S., et al.
Published: (2015)
Colorectal cancer deaths attributable to nonuse of screening in the United States
by: Meester, R., et al.
Published: (2015)
by: Meester, R., et al.
Published: (2015)
Cost-effectiveness of colorectal cancer screening
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2011)
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2011)
How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?
by: Wilschut, J., et al.
Published: (2011)
by: Wilschut, J., et al.
Published: (2011)
Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between the United States, spain, and the Netherlands
by: Kroep, S., et al.
Published: (2014)
by: Kroep, S., et al.
Published: (2014)
Cost-savings to medicare from pre-medicare colorectal cancer screening
by: Goede, S., et al.
Published: (2015)
by: Goede, S., et al.
Published: (2015)
Validation of Models Used to Inform Colorectal Cancer Screening Guidelines
by: Rutter, C., et al.
Published: (2015)
by: Rutter, C., et al.
Published: (2015)
European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition Introduction
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)
Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
by: Goede, S., et al.
Published: (2013)
by: Goede, S., et al.
Published: (2013)
State disparities in colorectal cancer rates: Contributions of risk factors, screening, and survival differences
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2015)
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2015)
Clarifying differences in natural history between models of screening: The case of colorectal cancer
by: Van Ballegooijen, M., et al.
Published: (2011)
by: Van Ballegooijen, M., et al.
Published: (2011)
Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening
by: Wilschut, J., et al.
Published: (2011)
by: Wilschut, J., et al.
Published: (2011)
Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
by: Goede, S., et al.
Published: (2017)
by: Goede, S., et al.
Published: (2017)
Colorectal cancer screening in Australia
by: Kuipers, E., et al.
Published: (2017)
by: Kuipers, E., et al.
Published: (2017)
Calibrating Parameters for Microsimulation Disease Models
by: Van Der Steen, A., et al.
Published: (2015)
by: Van Der Steen, A., et al.
Published: (2015)
The Impact of Uncertainty in Barrett's Esophagus Progression Rates on Hypothetical Screening and Treatment Decisions
by: Kroep, S., et al.
Published: (2015)
by: Kroep, S., et al.
Published: (2015)
A systematic comparison of microsimulation models of colorectal cancer: The role of assumptions about adenoma progression
by: Kuntz, K., et al.
Published: (2011)
by: Kuntz, K., et al.
Published: (2011)
Nonbleeding adenomas: Evidence of systematic false-negative fecal immunochemical test results and their implications for screening effectiveness - A modeling study
by: Van Der Meulen, M., et al.
Published: (2016)
by: Van Der Meulen, M., et al.
Published: (2016)
Variation in adenoma detection rate and the lifetime benefits and cost of colorectal cancer screening: A microsimulation model
by: Meester, R., et al.
Published: (2015)
by: Meester, R., et al.
Published: (2015)
Attendance and diagnostic yield of repeated two-sample faecal immunochemical test screening for colorectal cancer
by: Kapidzic, A., et al.
Published: (2015)
by: Kapidzic, A., et al.
Published: (2015)
Development of new non-invasive tests for colorectal cancer screening: The relevance of information on adenoma detection
by: Haug, U., et al.
Published: (2015)
by: Haug, U., et al.
Published: (2015)
Sojourn time of preclinical colorectal cancer by sex and age: Estimates from the german national screening colonoscopy database
by: Brenner, H., et al.
Published: (2011)
by: Brenner, H., et al.
Published: (2011)
An Accurate Cancer Incidence in Barrett's Esophagus: A Best Estimate Using Published Data and Modeling
by: Kroep, S., et al.
Published: (2015)
by: Kroep, S., et al.
Published: (2015)
Assessment of a cancer screening program
by: Rabeneck, L., et al.
Published: (2015)
by: Rabeneck, L., et al.
Published: (2015)
Adherence to colorectal cancer screening: Four rounds of faecal immunochemical test-based screening
by: Van Der Vlugt, M., et al.
Published: (2017)
by: Van Der Vlugt, M., et al.
Published: (2017)
Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths
by: Zauber, A., et al.
Published: (2012)
by: Zauber, A., et al.
Published: (2012)
Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2013)
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2013)
Gender Differences in Fecal Immunochemical Test Performance for Early Detection of Colorectal Neoplasia
by: Kapidzic, A., et al.
Published: (2015)
by: Kapidzic, A., et al.
Published: (2015)
Cost Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer
by: Gini, A., et al.
Published: (2018)
by: Gini, A., et al.
Published: (2018)
Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program
by: Wieten, E., et al.
Published: (2016)
by: Wieten, E., et al.
Published: (2016)
Second-Look Colonoscopies and the Impact on Capacity in FIT-Based Colorectal Cancer Screening
by: Grobbee, E., et al.
Published: (2015)
by: Grobbee, E., et al.
Published: (2015)
Do men and women need to be screened differently with fecal immunochemical testing? A cost-effectiveness analysis
by: Van Der Meulen, M., et al.
Published: (2017)
by: Van Der Meulen, M., et al.
Published: (2017)
Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test
by: Meester, R., et al.
Published: (2016)
by: Meester, R., et al.
Published: (2016)
A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening
by: Grobbee, E., et al.
Published: (2016)
by: Grobbee, E., et al.
Published: (2016)
Similar Items
-
Should colorectal cancer screening be considered in elderly persons without previous screening?: A cost-effectiveness analysis
by: Van Hees, F., et al.
Published: (2014) -
Personalizing Colonoscopy Screening for Elderly Individuals Based on Screening History, Cancer Risk, and Comorbidity Status Could Increase Cost Effectiveness
by: Van Hees, F., et al.
Published: (2015) -
Contribution of screening and survival differences to racial disparities in colorectal cancer rates
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012) -
The appropriateness of more intensive colonoscopy screening than recommended in medicare beneficiaries: A modeling study
by: Van Hees, F., et al.
Published: (2014) -
Developing a score chart to improve risk stratification of patients with colorectal adenoma
by: Van Heijningen, E., et al.
Published: (2016)